Amedeo's Top 20

Amedeo Smart

Independent Medical Education


08 July 2019

Multidisciplinary Journal Club

  1. Neumann JT, Twerenbold R, Ojeda F, Sorensen NA, et al.
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med 2019;380:2529-2540.

  1. Chen LY, Chung MK, Allen LA, Ezekowitz M, et al.
    Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
    Circulation 2018.

  2. Watanabe H, Domei T, Morimoto T, Natsuaki M, et al.
    Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
    JAMA 2019;321:2414-2427.

  3. Johnston SC, Elm JJ, Easton JD, Farrant M, et al.
    Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial.
    Circulation 2019.

  4. Weiss DJ, Lucas TCD, Nguyen M, Nandi AK, et al.
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling study.
    Lancet 2019.

  1. Hahn JY, Song YB, Oh JH, Chun WJ, et al.
    Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
    JAMA 2019;321:2428-2437.

  2. Reig A, Sese P, Pares A.
    Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.
    Am J Gastroenterol 2017.

  3. Ineichen BV, Moridi T, Granberg T, Piehl F, et al.
    Rituximab treatment for multiple sclerosis.
    Mult Scler 2019.

  4. Dale KD, Trauer JM, Dodd PJ, Houben RMGJ, et al.
    Estimating long-term tuberculosis reactivation rates in Australian migrants.
    Clin Infect Dis 2019.

  5. Sereti I, Gulick RM, Krishnan S, Migueles SA, et al.
    ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.
    J Acquir Immune Defic Syndr 2019;81:456-462.

  1. Danese S, Argollo M, Le Berre C, Peyrin-Biroulet L, et al.
    JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?
    Gut 2019.

  2. Walther CP, Erickson KF.
    The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins.
    Kidney Int 2019;96:22-25.

  3. Lee S, Fujita K, Negoro E, Morishita T, et al.
    The impact of diagnostic wait time on the survival of patients with diffuse large B-cell lymphoma: effect modification by the International Prognostic Index.
    Br J Haematol 2019.

  4. Magkos F.
    Metabolically healthy obesity: what's in a name?
    Am J Clin Nutr 2019.

  5. Katagi H, Louis N, Unruh D, Sasaki T, et al.
    Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma.
    Clin Cancer Res 2019.

  1. Knox NC, Forbes JD, Peterson CL, Van Domselaar G, et al.
    The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
    Am J Gastroenterol 2019.

  2. Chavassieux P, Chapurlat R, Portero-Muzy N, Roux JP, et al.
    Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment.
    J Bone Miner Res 2019.

  3. Nguyen H, Lee JY, Sanberg PR, Napoli E, et al.
    Eye Opener in Stroke.
    Stroke 2019.

  4. Wong SM, Almana N, Choi J, Hu J, et al.
    Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol 2019.

  5. Fornvik D, Aaltonen KE, Chen Y, George AM, et al.
    Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment.
    Breast Cancer Res Treat 2019.


more..


Privacy Policy